Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rational Design of Bioactive, Modularly Assembled Aminoglycosides Targeting the RNA that Causes Myotonic Dystrophy Type 1
Jessica L. Childs‐Disney, Raman Parkesh, Masayuki Nakamori, et al.
ACS Chemical Biology (2012) Vol. 7, Iss. 12, pp. 1984-1993
Open Access | Times Cited: 58

Showing 26-50 of 58 citing articles:

Structures of RNA repeats associated with neurological diseases
Leszek Błaszczyk, W. Rypniewski, Agnieszka Kiliszek
Wiley Interdisciplinary Reviews - RNA (2017) Vol. 8, Iss. 4
Closed Access | Times Cited: 30
A Dimeric 2,9‐Diamino‐1,10‐phenanthroline Derivative Improves Alternative Splicing in Myotonic Dystrophy Type 1 Cell and Mouse Models
Jinxing Li, Masayuki Nakamori, Jun Matsumoto, et al.
Chemistry - A European Journal (2018) Vol. 24, Iss. 68, pp. 18115-18122
Closed Access | Times Cited: 30
Structure and Dynamics of RNA Repeat Expansions That Cause Huntington’s Disease and Myotonic Dystrophy Type 1
Jonathan L. Chen, Damian M. VanEtten, Matthew A. Fountain, et al.
Biochemistry (2017) Vol. 56, Iss. 27, pp. 3463-3474
Open Access | Times Cited: 29
Integrating Display and Delivery Functionality with a Cell Penetrating Peptide Mimic as a Scaffold for Intracellular Multivalent Multitargeting
Yugang Bai, Lien Nguyen, Ziyuan Song, et al.
Journal of the American Chemical Society (2016) Vol. 138, Iss. 30, pp. 9498-9507
Closed Access | Times Cited: 27
Gini Coefficients as a Single Value Metric to Define Chemical Probe Selectivity
Andrei Ursu, Jessica L. Childs‐Disney, Alicia J. Angelbello, et al.
ACS Chemical Biology (2020) Vol. 15, Iss. 8, pp. 2031-2040
Open Access | Times Cited: 25
Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy
Anchel González-Barriga, Julia Kranzen, Huib J. E. Croes, et al.
PLoS ONE (2015) Vol. 10, Iss. 3, pp. e0121556-e0121556
Open Access | Times Cited: 25
Combination Treatment of Erythromycin and Furamidine Provides Additive and Synergistic Rescue of Mis-splicing in Myotonic Dystrophy Type 1 Models
Jana R. Jenquin, Hongfen Yang, Robert W. Huigens, et al.
ACS Pharmacology & Translational Science (2019) Vol. 2, Iss. 4, pp. 247-263
Open Access | Times Cited: 24
Rational design of chemical genetic probes of RNA function and lead therapeutics targeting repeating transcripts
Matthew D. Disney
Drug Discovery Today (2013) Vol. 18, Iss. 23-24, pp. 1228-1236
Open Access | Times Cited: 26
An Evolved RNA Recognition Motif That Suppresses HIV-1 Tat/TAR-Dependent Transcription
David W. Crawford, Brett D. Blakeley, Po‐Han Chen, et al.
ACS Chemical Biology (2016) Vol. 11, Iss. 8, pp. 2206-2215
Open Access | Times Cited: 23
Cells of Matter—In Vitro Models for Myotonic Dystrophy
Magdalena Matłoka, Arnaud F. Klein, Fredérique Rau, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 20
A Ligand That Targets CUG Trinucleotide Repeats
Jinxing Li, Jun Matsumoto, Li‐Ping Bai, et al.
Chemistry - A European Journal (2016) Vol. 22, Iss. 42, pp. 14881-14889
Closed Access | Times Cited: 19
CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model
Ami Ketley, Marzena Wojciechowska, Sonja Ghidelli-Disse, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 541
Open Access | Times Cited: 18
Synthesis of Janus Compounds for the Recognition of G-U Mismatched Nucleobase Pairs
Gerard Artigas, Vicente Marchán
The Journal of Organic Chemistry (2013) Vol. 78, Iss. 21, pp. 10666-10677
Open Access | Times Cited: 19
Development of aDrosophila melanogasterspliceosensor system forin vivohigh-throughput screening in myotonic dystrophy type 1
Irma García-Alcover, Jordi Colonques-Bellmunt, Raquel Garijo, et al.
Disease Models & Mechanisms (2014)
Open Access | Times Cited: 14
A Toxic RNA Templates the Synthesis of Its Own Fluorogenic Inhibitor by Using a Bio-orthogonal Tetrazine Ligation in Cells and Tissues
Alicia J. Angelbello, Matthew D. Disney
ACS Chemical Biology (2020) Vol. 15, Iss. 7, pp. 1820-1825
Open Access | Times Cited: 11
Ametantrone-based compounds as potential regulators of Tau pre-mRNA alternative splicing
Gerard Artigas, Paula López‐Senín, Carlos González, et al.
Organic & Biomolecular Chemistry (2014) Vol. 13, Iss. 2, pp. 452-464
Open Access | Times Cited: 10
A Chemical Inhibitor of the Skp2/p300 Interaction that Promotes p53‐Mediated Apoptosis
Misook Oh, Ji Hoon Lee, Heejo Moon, et al.
Angewandte Chemie (2015) Vol. 128, Iss. 2, pp. 612-616
Closed Access | Times Cited: 9
Pluripotent Stem Cell-Based Drug Screening Reveals Cardiac Glycosides as Modulators of Myotonic Dystrophy Type 1
Yves Maury, Pauline Poydenot, Benjamin Brinon, et al.
iScience (2018) Vol. 11, pp. 258-271
Open Access | Times Cited: 9
Dynamic combinatorial chemistry as a rapid method for discovering sequence-selective RNA-binding compounds
John D. McAnany, Benjamin L. Miller
Methods in enzymology on CD-ROM/Methods in enzymology (2019), pp. 67-84
Closed Access | Times Cited: 8
Optimization of the Linker Domain in a Dimeric Compound that Degrades an r(CUG) Repeat Expansion in Cells
Raphael I. Benhamou, Masahito Abe, Shruti Choudhary, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 14, pp. 7827-7839
Open Access | Times Cited: 8
A Dynamic Combinatorial Approach for Identifying Side Groups that Stabilize DNA-Templated Supramolecular Self-Assemblies
Delphine Paolantoni, Sonia Cantel, Pascal Dumy, et al.
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 2, pp. 3609-3625
Open Access | Times Cited: 7
Synthesis and Tau RNA Binding Evaluation of Ametantrone-Containing Ligands
Gerard Artigas, Vicente Marchán
The Journal of Organic Chemistry (2015) Vol. 80, Iss. 4, pp. 2155-2164
Open Access | Times Cited: 5
Myotonic Dystrophy
Masayuki Nakamori, Masanori Takahashi
Springer eBooks (2016), pp. 39-61
Closed Access | Times Cited: 4
Macrocyclization of a Ligand Targeting a Toxic RNA Dramatically Improves Potency
Raphael I. Benhamou, Simon Vézina‐Dawod, Shruti Choudhary, et al.
ChemBioChem (2020) Vol. 21, Iss. 22, pp. 3229-3233
Open Access | Times Cited: 5
Therapeutic development in myotonic dystrophy
Masanori Takahashi, Masayuki Nakamori, Hideki Mochizuki
Rinsho Shinkeigaku (2014) Vol. 54, Iss. 12, pp. 1077-1079
Open Access | Times Cited: 2

Scroll to top